Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±¹Á¦Àü¸³¼±Áõ»óÁ¡¼ö: ȯÀÚ ½º½º·Î ÀÛ¼ºÇÑ °Í°ú Àǻ簡 Á¶»çÇÑ °ÍÀÇ ºÒÀÏÄ¡ The International Prostate Symptom Score: Discrepancies between Self-administration and Physician-administration

´ëÇѺñ´¢±â°úÇÐȸÁö 2007³â 48±Ç 5È£ p.500 ~ 504
Á¶ÈñÁÖ, °­Á¤À±, À¯Å¹±Ù,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶ÈñÁÖ ( Cho Hee-Joo ) 
À»Áö´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

°­Á¤À± ( Kang Jeong-Yoon ) 
À»Áö´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
À¯Å¹±Ù ( Yoo Tag-Keun ) 
À»Áö´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract


Purpose: The International Prostate Symptom Score (IPSS) is the most commonly used scoring system to quantify the lower urinary tract symptoms of benign prostate hyperplasia. The objective of this study was to measure any discrepancies in the Korean version of the IPSS when it is administered by the patients themselves as opposed to when it was administered by the physician.

Materials and Methods: Seventy two patients were asked to fill out two IPSS questionnaires during their first visit; one was self-administered and the other was administered by a physician in an interview. The total IPSS, quality of life and the individual questions were compared between the two modes of administration.

Results: Statistically significant differences were found in the mean total IPSS(16.9?8.44 versus 15.0?7.53, respectively) and the scores on questions 3(intermittency) and 4(urgency) between the self and physician administered IPSS(2.40?2.03 versus 1.47?1.88 and 1.86?1.87 versus 1.26?1.58, respectively). Thirty one patients(44.3%) demonstrated a difference of more than 3 points on the total IPSS score.

Conclusions: This study suggests that there may be discrepancies between the self and physician administered IPSS scores. Therefore, physicians should review the score of each question, and especially those on intermittency and urgency.(Korean J Urol 2007;48:500-504)

Å°¿öµå

International Prostate Symptom Score;Urinary tract;Symptoms

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS